Schedule 13G ownership disclosure

Context Therapeutics, Inc.

Security class unavailable · CUSIP: 21077P108

Event date: 2023-01-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-000970
Form type
SC 13G/A
Filer
Context Therapeutics Inc.
CIK
CIK 1842952
Filed
Jan 09, 2023
Reporting period
Jan 09, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub